Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Employee Benefits

Eli Lilly to cut insulin cost and cap out-of-pocket expenses for drug

March 02, 2023 Reprints

Eli Lilly & Co. is slashing prices on its most-prescribed insulins and capping out-of-pocket costs for patients amid pressure from consumers and the Biden administration, Axios reports. The prices of Humalog, the company's top insulin product, and Humulin will fall 70% in the fourth quarter, according to the company. The price of generic insulin lispro, which is the same product as Humalog, will drop May 1 to $25 a vial, which Lilly says is less than Humalog cost in 1999. Lilly also said it would cap out-of-pocket costs for its insulin at $35 a month at some retail pharmacies.

Help

Eli Lilly to cut insulin cost and cap out-of-pocket expenses for drug

Readers Poll

Most Read in Employee Benefits

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources